Tumours could be reduced by targeting genetic material driving their growth with a new drug in early-stage trials
Scientists have raised hopes of treating some of the most aggressive cases of cancer by targeting small fragments of rogue DNA that help tumours thrive and become resistant to chemotherapy.
The breakthrough emerged from a US-UK study that found many hard-to-treat cancers contained loops of malignant genetic material that were crucial for the tumours to survive and withstand treatment.
About Author
More Stories
Experts warn of mental health risks after rise in magic mushroom use
Esports are booming in Africa – but can its infrastructure keep pace?
Canadian researchers trial nature trick to boost mood in winter